RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) - INTERIM ANALYSIS OF A PHASE-II STUDY OF ONCE WEEKLY TIMES 8 DOSING IN PATIENTS WITH RELAPSED LOW-GRADEOR FOLLICULAR NON-HODGKINS-LYMPHOMA

PIRO L WHITE CA LOPEZ AJG JANAKIRAMAN N BECK TM SELANDER K DOWDEN S CZUCZMAN M LYNCH JW KOLITZ JE JAIN V

L. Piro et al., RITUXAN(TM) (RITUXIMAB, IDEC-C2B8) - INTERIM ANALYSIS OF A PHASE-II STUDY OF ONCE WEEKLY TIMES 8 DOSING IN PATIENTS WITH RELAPSED LOW-GRADEOR FOLLICULAR NON-HODGKINS-LYMPHOMA, Blood, 90(10), 1997, pp. 2272-2272

NO

Hematology

Blood → ACNP

00064971

90

10

1997

1

1

2272 - 2272

ISI

0006-4971(1997)90:10<2272:R(I-IA>2.0.ZU;2-K